Public-registry site landscape for NCT04952753, a Metastatic Colorectal Cancer study sponsored by Novartis Pharmaceuticals. All data below is from public sources; Eichor is not affiliated with the sponsor.
| Trial | NCT04952753 (registry record) |
| Sponsor | Novartis Pharmaceuticals |
| Condition(s) | Metastatic Colorectal Cancer |
| Phase | PHASE2 |
| Listed sites | 55 |
| Site countries | United States, Australia, Belgium, Canada, Czechia, France, Germany, Hong Kong, Israel, Italy, Japan, Singapore |
Eichor generates a preliminary site-risk snapshot for NCT04952753 — how the roster screens on competing-trial load, enrollment track record, and PI–indication fit — free, usually same day. Request it here →